{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:31:01Z","timestamp":1787610661333,"version":"build-2736575974"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>Multidrug-resistant (MDR) bacteria pose a significant clinical threat to human health, but the development of antibiotics cannot meet the urgent need for effective agents, especially those that can kill persisters and biofilms. Here, we reported that nigericin showed potent bactericidal activity against various clinical MDR Gram-positive bacteria, persisters and biofilms, with low frequencies of resistance development. Moreover, nigericin exhibited favorable <jats:italic>in vivo<\/jats:italic> efficacy in deep-seated mouse biofilm, murine skin and bloodstream infection models. With <jats:italic>Staphylococcus aureus<\/jats:italic>, nigericin disrupted ATP production and electron transport chain; cell death was associated with altered membrane structure and permeability. Obtaining nigericin-resistant\/tolerant mutants required multiple rounds of challenge, and, cross-resistance to members of several antimicrobial classes was absent, probably due to distinct nigericin action with the GraSR two-component regulatory system. Thus, our work reveals that nigericin is a promising antibiotic candidate for the treatment of chronic or recurrent infections caused by Gram-positive bacteria.<\/jats:p>","DOI":"10.3389\/fcimb.2022.1055929","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:59:01Z","timestamp":1671515941000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Nigericin is effective against multidrug resistant gram-positive bacteria, persisters, and biofilms"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoli","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"III","DOI":"10.1016\/s0079-6336(76)80015-0","article-title":"Tetrazolium salts and formazans","volume":"9","author":"Altman","year":"1976","journal-title":"Prog. Histochem. Cytochem."},{"key":"B2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.plasmid.2005.05.005","article-title":"Allelic replacement in staphylococcus aureus with inducible counter-selection","volume":"55","author":"Bae","year":"2006","journal-title":"Plasmid"},{"key":"B4","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1128\/MMBR.49.4.359-378.1985","article-title":"Regulation of cytoplasmic pH in bacteria","volume":"359","author":"Booth","year":"1985","journal-title":"Microbiological Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1080\/08927014.2011.626899","article-title":"Resistance of bacterial biofilms to disinfectants: A review","volume":"27","author":"Bridier","year":"2011","journal-title":"Biofouling"},{"key":"B7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-319-32189-9_6","article-title":"Using biophysics to monitor the essential protonmotive force in bacteria","volume":"915","author":"Chen","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B8","volume-title":"Performance standards for antimicrobial susceptibility testing, M100","year":"2021"},{"key":"B9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ampbs.2014.08.001","article-title":"Energetics of pathogenic bacteria and opportunities for drug development","volume":"65","author":"Cook","year":"2014","journal-title":"Adv. Microb. Physiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","article-title":"Collapsing the proton motive force to identify synergistic combinations against staphylococcus aureus","volume":"20","author":"Farha","year":"2013","journal-title":"Chem. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1146\/annurev-micro-020518-115650","article-title":"Bacterial persisters and infection: Past, present, and progressing","volume":"73","author":"Gollan","year":"2019","journal-title":"Annu. Rev. Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1128\/AAC.41.3.523","article-title":"Characterization of the potent in vitro and in vivo antimalarial activities of ionophore compounds","volume":"41","author":"Gumila","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00537","article-title":"Gas plasma pre-treatment increases antibiotic sensitivity and persister eradication in methicillin-resistant staphylococcus aureus","volume":"9","author":"Guo","year":"2018","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/s41579-021-00585-w","article-title":"Antibiofilm activity of host defence peptides: complexity provides opportunities","volume":"19","author":"Hancock","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf4268","article-title":"Mechanisms of bacterial persistence during stress and antibiotic exposure","volume":"354","author":"Harms","year":"2016","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0065-2911(08)60439-7","article-title":"Antimicrobial agents and membrane function","volume":"4","author":"Harold","year":"1969","journal-title":"Adv. Microb. Physiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1128\/jb.96.6.2025-2034.1968","article-title":"Inhibition of membrane transport in streptococcus faecalis by uncouplers of oxidative phosphorylatio","volume":"96","author":"Harold","year":"1969","journal-title":"J. Bacteriol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1021\/acs.chemrev.0c01214","article-title":"The antibiotic resistome: A guide for the discovery of natural products as antimicrobial agents","volume":"121","author":"Hobson","year":"2021","journal-title":"Chem. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.tube.2017.09.001","article-title":"Ionophore A23187 shows anti-tuberculosis activity and synergy with tebipenem","volume":"107","author":"Huang","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7164\/antibiotics.45.556","article-title":"Circumvention of multidrug resistance in human carcinoma KB cells by polyether antibiotics","volume":"45","author":"Kawada","year":"1992","journal-title":"J. Antibiot (Tokyo)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1517\/17460440802661443","article-title":"Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites","volume":"4","author":"Kevin Ii","year":"2009","journal-title":"Expert Opin. Drug Discov."},{"key":"B23","doi-asserted-by":"publisher","first-page":"43085","DOI":"10.1039\/D0RA05137C","article-title":"Approach to nigericin derivatives and their therapeutic potential","volume":"10","author":"Kumarsahu","year":"2020","journal-title":"RSC Adv."},{"key":"B24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41557-019-0378-7","article-title":"Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant staphylococcus aureus, persisters and biofilms","volume":"12","author":"Le","year":"2020","journal-title":"Nat. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nrd3975","article-title":"Platforms for antibiotic discovery","volume":"12","author":"Lewis","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1128\/JB.00765-12","article-title":"The MerR-like transcriptional regulator BrlR contributes to pseudomonas aeruginosa biofilm tolerance","volume":"194","author":"Liao","year":"2012","journal-title":"J. Bacteriol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41557-020-00601-1","article-title":"Expanding the antibacterial selectivity of polyether ionophore antibiotics through diversity-focused semisynthesis","volume":"13","author":"Lin","year":"2021","journal-title":"Nat. Chem."},{"key":"B28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/phar.1868","article-title":"Past, present, and future of antibacterial economics: Increasing bacterial resistance, limited antibiotic pipeline, and societal implications","volume":"37","author":"Luepke","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.1128\/AAC.00474-12","article-title":"Induction of mycobacterial resistance to quinolone class antimicrobials","volume":"56","author":"Malik","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B30","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1128\/Aac.01035-09","article-title":"Novel approach for comparing the abilities of quinolones to restrict the emergence of resistant mutants during quinolone exposure","volume":"54","author":"Malik","year":"2010","journal-title":"Antimicrobial Agents Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1128\/AAC.00209-07","article-title":"Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in staphylococcus aureus","volume":"51","author":"Meehl","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1469-185X.1966.tb01501.x","article-title":"Chemiosmotic coupling in oxidative and photosynthetic phosphorylation","volume":"41","author":"Mitchell","year":"1966","journal-title":"Biol. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"VMBF-0016-2015","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.12688\/f1000research.5512.2","article-title":"Diversity of two-component systems: insights into the signal transduction mechanism by the staphylococcus aureus two-component system GraSR","volume":"3","author":"Muzamal","year":"2014","journal-title":"F1000Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1128\/AAC.00534-07","article-title":"Mutated response regulator graR is responsible for phenotypic conversion of staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance","volume":"52","author":"Neoh","year":"2008","journal-title":"Antimicrobial Agents Chemother."},{"key":"B36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.pa.22.040182.002341","article-title":"Pharmacology and toxicology of the monovalent carboxylic ionophores","volume":"22","author":"Pressman","year":"1982","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1073\/pnas.58.5.1949","article-title":"Antibiotic-mediated transport of alkali ions across lipid barriers","volume":"58","author":"Pressman","year":"1967","journal-title":"Natl. Acad. Sci. U.S.A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"5054","DOI":"10.1128\/AAC.00785-12","article-title":"Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition","volume":"56","author":"Smith","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1099\/jmm.0.000304","article-title":"Effect of clpP and clpC deletion on persister cell number in staphylococcus aureus","volume":"65","author":"Springer","year":"2016","journal-title":"Med. Microbiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cell.2020.04.001","article-title":"A deep learning approach to antibiotic discovery (vol 180, pg 688.e1, 2020)","volume":"181","author":"Stokes","year":"2020","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"104","DOI":"10.7324\/JAPS.2013.3520","article-title":"Antibacterial activity of 1-methyl ester-nigericin from streptomyces hygroscopicus BRM10; an endophyte in alpinia galanga","volume":"3","author":"Taechowisan","year":"2013","journal-title":"J. Appl. Pharm. Sci."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006012","article-title":"Convergence of staphylococcus aureus persister and biofilm research: Can biofilms be defined as communities of adherent persister cells","volume":"12","author":"Waters","year":"2016","journal-title":"PLoS Pathog."},{"key":"B44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10600-009-9350-x","article-title":"Structure\u2013antibacterial relationship of nigericin derivatives","volume":"45","author":"Wu","year":"2009","journal-title":"Chem. Nat. Compd."},{"key":"B45","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1128\/IAI.05669-11","article-title":"The staphylococcus aureus two-component regulatory system, GraRS, senses and confers resistance to selected cationic antimicrobial peptides","volume":"80","author":"Yang","year":"2012","journal-title":"Infect. Immun."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1055929\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T05:59:06Z","timestamp":1671515946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1055929\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":45,"alternative-id":["10.3389\/fcimb.2022.1055929"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1055929","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"article-number":"1055929"}}